4512-0204

4512-0204 Nasal Naloxone Pilot Expansion

Spending Categories

Spending Category
FY2023 Expended
FY2024 Expended
FY2025 Expended
FY2026 Projected Spending
FY2027 House 2
Operating Expenses
625,207
1,140,480
1,150,000
1,298,718
1,298,718
Grants & Subsidies
0
25,000
25,000
0
0
Total
625,207
1,165,480
1,175,000
1,298,718
1,298,718
Loading...